Thursday, 30 March 2023 12:31
PBS CRITERIA EXPANDED FOR COVID-19 ORAL ANTI-VIRAL
FROM April 1, 2023, the eligibility criteria for access to PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets) on the Pharmaceutical Benefits Scheme (PBS) will be expanded to include people between 60-69 years of age with mild to moderate COVID-19 with one additional risk factor for developing severe disease.
Pfizer Australia and New Zealand Medical Director, Dr Krishan Thiru, said: “As winter approaches, we anticipate a heightened impact of COVID-19 in the community, as has occurred in the previous three years. This widening of PBS eligibility criteria means many more Australians most at risk of severe disease may be able to access PAXLOVID through the PBS if they test positive for COVID-19, and take treatment at home.”
PAXLOVID is a prescription only oral medicine taken twice-daily for five days. It should be taken as soon as possible after a diagnosis of COVID-19, and within five days of symptoms appearing.
Published in
Default Set
Thursday, 30 March 2023 08:42
FLOOD RECOVERY GRANTS AVAILABLE
Funding up to $10,000 for community activities
AFTER the loss and distress resulting from the 2022 floods, the Western Sydney Primary Health Network (WSPHN) is offering wellbeing and resilience grants to support flood-affected communities in Western Sydney.
AFTER the loss and distress resulting from the 2022 floods, the Western Sydney Primary Health Network (WSPHN) is offering wellbeing and resilience grants to support flood-affected communities in Western Sydney.
Published in
Default Set
Saturday, 25 March 2023 17:06
FORD DEBUTS ALL ELECTRIC EXPLORER SV
Stylish with massaging driver's seat
MATT BROGAN
MATT BROGAN
FORD debuted its all-electric Explorer SUV this week, with the Volkswagen-based five-seater to go on sale in Europe later this year priced from €45,000 ($A72,000) plus on-road costs.
Published in
Default Set